Boston Bioprocess is a CDMO platform for bringing microbes through pilot scale to industrial scale. The company provides strain evaluation, process development, and scale-up solutions to companies seeking to commercialize yeast, bacteria, and fungal microbes for both fermentation and downstream services. The company uses a large bioprocess database and expertise to effectively remove knowledge and capacity bottlenecks in the transition from lab to pilot, then to commercial manufacturing for bio-based product development.